Latest News - GHR 15®
Anti-aging Health News Stories
Periodically we scan Health News from the Internet and submit them here for your reading leisure.
Female sex drive problems still a mystery
CLEVELAND, Nov. 7 (UPI) U.S. medical experts have been unable to find an approved and successful medication that will help a woman overcome a marked drop in sexual drive.
While testosterone products have been embraced overseas, related products have failed to gain approval in the United States because of arguments against their effectiveness and safety, the Cleveland Plain Dealer said Wednesday.
With such proposed medical treatments failing to gain approval from the Food and Drug Administration, women suffering from sexual dysfunction have been left with few options.
Psychiatrist Dr. Susan Rako, who wrote the book "The Hormone of Desire," has become a champion for testosterone-based products for female sexual dysfunction.
She says that stereotypes about testosterone's effects on women, along with the FDA's stance on the hormone's use for such treatments, are the key roadblocks.
"People used to think that if you gave testosterone to women, you turned them into men," she told the newspaper.
"The problem has been that the FDA has not identified testosterone deficiency as a state that needs to be treated," she added.
Source: United Press International
Polygamous men have lower testosterone
LAS VEGAS, Oct. 11 (UPI) U.S. researchers studying male herders in Kenya find men with more than one wife have lower testosterone levels than monogamously married men.
The study, published in Current Anthropology, also found monogamously married men have lower testosterone levels than single men, and married men who are considered aloof spouses and provide minimal parenting have much lower testosterone levels than single, unmarried men.
Researchers Peter Gray of the University of Nevada, Peter Ellison of Harvard University and Benjamin Campbell of Boston University, looked for links between male testosterone levels and marital status among modern-day herders in northern Kenya, known as the Ariaal.
When herd boys reach puberty, they are initiated, become warriors and accumulate livestock. They seldom marry and have children until age 30.
Less than 2 percent of the herders consider their wives a source of emotional support. Rather, they seem to value social bonds with male peers more than spousal bonds or familial bonds, the researchers said.
Source: United Press International
Lack of testosterone risk rises with age
WATERTOWN, Mass., Sept. 7 (UPI) Less than 6 percent of the male population suffer from low testosterone, however, the number rises substantially with age, a U.S. study found.
"Low levels of testosterone impact many aspects of male physiology -- such as low libido, erectile dysfunction, osteoporosis or fracture," Andre B. Araujo, of the New England Research Institutes in Watertown, Mass., said in a statement. "This is particularly significant because the ongoing aging of the U.S. male population is likely to cause the number of men suffering from androgen deficiency to increase appreciably."
The researchers analyzed data on 1,475 randomly selected men ages of 30-79 in Boston and compiled data on testosterone, symptoms of hormone deficiency and medications that may affect sex hormone levels.
The study, scheduled to be published in the November issue of the Journal of Clinical Endocrinology & Metabolism, found 5.6 percent of men in the study had symptomatic androgen deficiency but for those 70 years or older the percentage was 18.4 percent.
The study also found low testosterone levels were associated with symptoms, however, many men with low testosterone levels were asymptomatic.
Source: United Press International
Long-lasting growth hormone is developed
SHEFFIELD, England, Sept. 6 (UPI) British researchers have developed a long-acting growth hormone that reduces the need for daily therapy treatments.
Most hormones and cytokines used today have a short life, requiring frequent therapeutic injections. But the new technology developed at the University of Sheffield means scientists and clinicians will be able to generate effective, long-acting hormones that promote growth during a minimum 10-day period with one injection.
The researchers said the technology might also be used to treat inflammatory diseases such as multiple sclerosis, cancer and metabolic maladies.
However, the scientists cautioned the research is only in its early stages and any drugs resulting from the study are several years away from approval.
The research is detailed in the journal Nature Medicine.
Source: United Press International
Testosterone patch aids women's sex desire
CLEVELAND, Aug. 15 (UPI) A U.S. study of women with hypoactive sexual desire disorder, or lack of sexual interest, showed improved sexual desire following testosterone treatment.
Two randomized double-blind, placebo-controlled trials in surgically postmenopausal -- uterus and ovaries removed -- women with hypoactive sexual desire disorder showed a low-dose transdermal testosterone patch treatment resulted in significant improvements in the frequency of satisfying sexual activity and sexual desire, said the study published in the The Journal of Sexual Medicine.
Study leader Dr. Sheryl Kingsberg, of Case Western Reserve University School of Medicine, in Cleveland, conducted the two trials involving 132 participants, who were interviewed after a six-month treatment period.
The findings showed a significant increase in frequency of satisfying sexual activity and sexual desire based on women experiencing the treatment as beneficial.
Source: United Press International
For Immediate Release - September 12, 2006
KNOXVILLE, TN - GHR 15 ANTI-AGING SUPPLEMENT EXCUSIVELY OWNED BY AAASI, INC., PROCEEDS TOWARD COMPLETION OF FEDERAL TRADEMARK REGISTRATION - AVAILABLE ONLY BY AAASI, INC. AUTHORIZED RESELLERS.
American Anti-Aging Society, Inc. announces that it is the sole owner of the trademark for GHR 15. AAASI, Inc. developed the Nation's best selling anti-aging formula and the trademark GHR 15 in Tennessee in 1997. The company has now completed the opposition period immediately prior to the official notice of federal registration for the trademark -- which will disallow any other entity to legally sell the same or similar product using the GHR 15 trademark.
GHR 15 is a revolutionary formula to naturally slow the aging process. GHR 15 is an all natural growth hormone releaser. The unique combination of ingredients stimulates the anterior pituitary gland to release your growth hormones to reverse the aging process of your body. GHR 15 is a non-chemical alternative to HGH injections. Now, with the help of GHR 15 you can look and feel younger than ever before without the cost or risk of HGH.
"AAASI, Inc. will clear the market of imitators and violators to ensure our customers have the best product available to them," said Ken Dawson, CEO, AAASI, Inc., "We want to clear up any confusion by our loyal customers and provide the best experience with America's best selling anti-aging supplement - GHR 15."
The federal trademark application is in the final phase, with the registration certificate expected in fourth quarter. The federal application serial number is 78639401.
.
